Literature DB >> 26173389

FY*A silencing by the GATA-motif variant FY*A(-69C) in a Caucasian family.

Martin Písačka1, Iuri Marinov1, Miroslava Králová1, Jana Králová1, Michaela Kořánová2, Miloš Bohoněk2, Chhavi Sood3, Gorka Ochoa-Garay3.   

Abstract

BACKGROUND: The c.1-67C variant polymorphism in a GATA motif of the FY promoter is known to result in erythroid-specific FY silencing, that is, in Fy(a-) and Fy(b-) phenotypes. A Caucasian donor presented with the very rare Fy(a-b-) phenotype and was further investigated. STUDY DESIGN AND METHODS: Genomic DNA was analyzed by sequencing to identify the cause of the Fy(a-b-) phenotype. Samples were collected from some of his relatives to establish a correlation between the serology and genotyping results. Red blood cells were analyzed by gel column agglutination and flow cytometry. Genomic DNA was analyzed on genotyping microarrays, by DNA sequencing and by allele-specific PCR.
RESULTS: In the donor, a single-nucleotide polymorphism T>C within the GATA motif was found at Position c.1-69 of the FY promoter and shown to occur in the FY*A allele. His genotype was found to be FY*A(-69C), FY*BW.01. In six FY*A/FY*B heterozygous members of the family, a perfect correlation was found between the presence vs. absence of the FY*A(-69C) variant allele and a Fy(a-) vs. Fy(a+) phenotype.
CONCLUSION: The location of the c.1-69C polymorphism in a GATA motif whose disruption is known to result in a Fy null phenotype, together with the perfect correlation between the presence of the FY*A(-69C) allele and the Fy(a-) phenotype support a cause-effect relationship between the two.
© 2015 AABB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26173389     DOI: 10.1111/trf.13221

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

Review 1.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

2.  ACKR1 Alleles at 5.6 kb in a Well-Characterized Renewable US Food and Drug Administration (FDA) Reference Panel for Standardization of Blood Group Genotyping.

Authors:  Kshitij Srivastava; Pavel P Khil; Emilia Sippert; Evgeniya Volkova; John P Dekker; Maria Rios; Willy A Flegel
Journal:  J Mol Diagn       Date:  2020-07-17       Impact factor: 5.568

3.  Serological and Molecular Study of the Duffy Blood Group among Malarial Endemic Region Residents in Brazil.

Authors:  Dante Langhi Júnior; Sérgio Albuquerque; Rui Serafim; Gustavo de Carvalho Duarte; Dimas Tadeu Covas; José O Bordin
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-05       Impact factor: 2.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.